The product was returned for evaluation.A mismatch between the graft (diameter 8mm) and its labeling (diameter 30mm) was confirmed.It was noticed that both inner and outer blisters were open.Upon investigation and review of the complaint device history records, it appears that this discrepancy is related to an isolated human error which occured during a manufacturing steps.As a correction, the corresponding mislabeled product was found and immediately segregated.As a corrective action, a working group is currently conducting an analysis of the issue to prevent such incident from reoccurring.In addition, the manufacturing staff has been informed of the issue and will be retrained.
|
The segregated product has been returned as part of a recall.No other product was involved in this issue.Additional narrative and corrected data: this mdr is one of a series of four resubmissions.Indeed, following the fda's email dated june 24th, 2020 informing us on an issue about the initial mdr #16402201-2016-00008 which was not received, and the confirmation of an error of submission environment on july 6th, 2020, an internal non-conformity report was initiated on july 6th, 2020 in order to investigate the root cause of the issue and take appropriate corrective actions.In this context, the mdr # 16402201-2016-00008 was resent on july 10th, 2020 and three additional mdr's were identified as affected by the same discrepancy (original submission in the test environment instead of the production environment): initial mdr # 1640201-2016-00007, supplemental report 1 for mdr # 16402201-2016-00004 and supplemental report 2 for mdr # 16402201-2015-00024.It is why we are resubmitting today the present report with the original data.Only the contact part g1-2 was corrected to provide the updated contact information and h10 was supplemented to add details concerning the resubmission.We apologize for this issue.
|